SI
ATRS

SII Investments’s Antares Pharma, Inc. ATRS Stock Holding History

SII Investments’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,800
Closed -$32K – 368
2017
Q4 		$32K Hold
15,800
– – ﹤0.01% 394
2017
Q3 		$50K Hold
15,800
– – ﹤0.01% 590
2017
Q2 		$50K Buy
+15,800
New +$44.8K ﹤0.01% 582
2016
Q3 		– Sell
-10,100
Closed -$11K – 646
2016
Q2 		$11K Sell
10,100
-23,000
-69% -$22.2K ﹤0.01% 583
2016
Q1 		$31K Buy
33,100
+21,500
+185% +$20.8K ﹤0.01% 569
2015
Q4 		$14K Sell
11,600
-29,000
-71% -$40.4K ﹤0.01% 456
2015
Q3 		$71K Buy
40,600
+28,000
+222% +$54.9K 0.01% 529
2015
Q2 		$26K Hold
12,600
– – ﹤0.01% 519
2015
Q1 		$35K Sell
12,600
-200
-2% -$507 ﹤0.01% 529
2014
Q4 		$36K Buy
12,800
+1,200
+10% +$2.7K ﹤0.01% 500
2014
Q3 		$23K Sell
11,600
-1,050
-8% -$2.29K ﹤0.01% 497
2014
Q2 		$36K Buy
+12,650
New +$38.1K 0.01% 471

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SII Investments's ATRS Position: Q1 2018 in Review

SII Investments sold out of Antares Pharma, Inc. (ATRS) in Q1 2018, closing a stake of 15,800 shares — an estimated $32K sold.

SII Investments first reported a position in ATRS in Q2 2014 and held it in 12 quarters. The position peaked at $71K in Q3 2015. 102 funds tracked by Wall St. Rank hold ATRS as of Q1 2018.

  • SII Investments reported no remaining Antares Pharma, Inc. position as of Q1 2018 after selling out during the quarter.
  • SII Investments sold 15,800 Antares Pharma, Inc. shares in Q1 2018, an estimated $32K.
  • SII Investments first reported a position in Antares Pharma, Inc. in Q2 2014 and held it in 12 quarters.
  • SII Investments's Antares Pharma, Inc. position peaked at $71K in Q3 2015.
  • 102 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2018.

Based on SII Investments's 13F filing for Q1 2018.